Generalized epilepsy with febrile seizures plus, type 2
MONDO:0011461Any febrile seizures, familial in which the cause of the disease is a mutation in the SCN1A gene.
Also known as: GEFS+, type 2, SCN1A febrile seizures, familial, febrile seizures, familial caused by mutation in SCN1A, generalized epilepsy with febrile seizures plus, type 2, GEFSP2, febrile seizures, familial, 3A
10 clinical trials for this condition and its sub-types, 3 tagged with Generalized epilepsy with febrile seizures plus, type 2 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Gene therapy trial aims to tame severe childhood epilepsy
Disease control Recruiting nowThis study tests a gene therapy called ETX101 for children with Dravet syndrome, a severe form of epilepsy caused by a genetic change. The treatment uses a harmless virus to deliver a working copy of the gene to help control seizures. The trial includes infants and children up to…
Phase 1/2 • Sponsor: Encoded Therapeutics • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Gene therapy hopes to tame severe childhood epilepsy
Disease control Recruiting nowThis early-stage trial tests a gene therapy called RC001 in children aged 2 to 18 with Dravet syndrome, a severe form of epilepsy caused by a genetic mutation. The therapy is given as a single injection into the spinal fluid. The main goal is to check safety and how the body proc…
Early phase 1 • Sponsor: Second Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC